Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
maxidex 1 mg/ml øjendråber, suspension
novartis healthcare a/s - dexamethason - øjendråber, suspension - 1 mg/ml
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
maxidex 1 mg/ml øjendråber, suspension
2care4 aps - dexamethason - øjendråber, suspension - 1 mg/ml
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
maxidex 1 mg/ml øjendråber, suspension
orifarm a/s - dexamethason - øjendråber, suspension - 1 mg/ml
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
maxidex 1 mg/ml øjendråber, suspension
paranova danmark a/s - dexamethason - øjendråber, suspension - 1 mg/ml
Den Europæiske Union -
dansk -
EMA (European Medicines Agency)
sugammadex piramal
piramal critical care b.v. - sugammadex sodium - neuromuskulær blokade - sugammadex - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults.
Den Europæiske Union -
dansk -
EMA (European Medicines Agency)
sugammadex mylan
mylan ireland limited - sugammadex sodium - neuromuskulær blokade - alle andre terapeutiske produkter - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
Den Europæiske Union -
dansk -
EMA (European Medicines Agency)
sugammadex fresenius kabi
fresenius kabi deutschland gmbh - sugammadex sodium - neuromuskulær blokade - alle andre terapeutiske produkter - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
Den Europæiske Union -
dansk -
EMA (European Medicines Agency)
sugammadex amomed
aop orphan pharmaceuticals gmbh - sugammadex sodium - neuromuskulær blokade - alle andre terapeutiske produkter - tilbagevendelse af neuromuskulær blokade induceret af rocuronium eller vecuronium. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
Den Europæiske Union -
dansk -
EMA (European Medicines Agency)
sugammadex adroiq
extrovis eu ltd. - sugammadex sodium - neuromuskulær blokade - alle andre terapeutiske produkter - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
Danmark -
dansk -
Lægemiddelstyrelsen (Danish Medicines Agency)
sugammadex "reddy" 100 mg/ml injektionsvæske, opløsning
reddy holding gmbh - sugammadexnatrium - injektionsvæske, opløsning - 100 mg/ml